Are we optimising outcomes in Australia's framework for the supply of plasma-derived medicines?

Albert Farrugia

doi:10.5694/mja16.00505

Are we optimising outcomes in Australia's framework for the supply of plasma-derived medicines?

Albert Farrugia

UWA Medical School

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	336-336.e1
Journal	Medical Journal of Australia
Volume	205
Issue number	7
DOIs	https://doi.org/10.5694/mja16.00505
Publication status	Published - 3 Oct 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5694/mja16.00505

Cite this

@article{e1aa623377924e329060ddae17da8517,

title = "Are we optimising outcomes in Australia's framework for the supply of plasma-derived medicines?",

keywords = "Australia, Biological Products, Blood Donors, Blood Preservation, Evidence-Based Medicine, Health Policy, Humans, Plasma, Letter",

author = "Albert Farrugia",

year = "2016",

month = oct,

day = "3",

doi = "10.5694/mja16.00505",

language = "English",

volume = "205",

pages = "336--336.e1",

journal = "Medical Journal of Australia",

issn = "0025-729X",